WHO ICTRP trial
Study on prevention of severe oral mucositis for head and neck cancer patients…
JPRN-UMIN000028813 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000028813 |
|---|---|
| Public title | Study on prevention of severe oral mucositis for head and neck cancer patients with radiotherapy |
| Scientific title | Study on prevention of severe oral mucositis for head and neck cancer patients with radiotherapy - Study on prevention of severe oral mucositis for head and neck cancer patients with radiotherapy |
| Primary sponsor | Nagasaki University Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | head and neck cancer |
| Interventions | When grade 1 oral mucositis develops, apply Lindelon VG ointment dissolved with olive oil. The application should be four times a day, after breakfast, after lunch, after dinner, before going to bed. |
| Registration date | Jan 9, 2017 |
| Target size | 10 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: